Filed before 2025Filed 10 August 2017
Homology Medicines, Inc. raised $83.5M
Homology Medicines, Inc., a pharmaceuticals company based in Bedford, MA, raised $83.5M in a new equity round, according to a filing dated 10 August 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 10 August 2017
- Round
- Equity round
- Amount sold
- $83.5M
- Offering size
- $83.5M
- Investors so far
- 19
- Based in
- Bedford, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 97% of the 1,645 tracked raises with an amount filed in 2017, and than 100% of the 40 in pharmaceuticals.
Homology Medicines, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 10 Aug 2017 | New filing | $83.5M | This raise |
| 16 Feb 2017 | Amended filing | $43.6M | Another raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.